All blog posts
Total 34 results for
Showing 34 out of 34 results
30 março 2020
What’s next for the UPC project? Our analysis following the German Federal Constitutional Court decision
20 março 2020
No plain sailing for the UPC – German Court Upholds Constitutional Challenge
28 fevereiro 2020
UK will not be a part of the UPC – government confirms
24 fevereiro 2020
Update on IP rights in the UK during the Brexit transition period and beyond
30 janeiro 2020
Brexit & IP - status quo for the transition period; changes to come post-transition
22 outubro 2019
Patent and Pharma Update, October 2019
11 setembro 2019
Updated HSF Legal Guide to Brexit published (including IP and Pharma sections)
14 janeiro 2019
Herbert Smith Freehills' Brexit Legal Guide updated - comparison of IP and pharma provisions in the draft Withdrawal Agreement versus the No Deal provisions promised by the UK Government
04 outubro 2018
UK Government launches consultation on role of MHRA post-Brexit and confirms commitment to underwrite Horizon 2020 funding
The UK Government has today launched a consultation on the role of the Medicines and Healthcare products Regulatory Agency (MHRA) post-Brexit "seeking …
01 setembro 2016
The Trade Secrets Directive - consistency of approach required, with or without Brexit
In her Editorial for the Journal of Intellectual Property Law and Practice, Rachel Montagnon (our IP professional support consultant) discusses the …
Showing 34 out of 34 results
Key contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Herbert Smith Freehills Kramer Kewei Joint Operation, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London